gefitinib 250 MG Oral Tablet

RxCUI: 349472
RxNorm name: gefitinib 250 MG Oral Tablet
Display name: gefitinib 250 MG Oral Tablet
Full name: gefitinib 250 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gefitinib	GEFITINIB	Natco Pharma USA LLC	1a3c0ce7-06a1-4e04-9106-14ddb2a866a5	2026-03-10	Warnings, Adverse reactions	Exact identifier rxcui: 349472
Gefitinib	GEFITINIB	Ingenus Pharmaceuticals, LLC	6402435f-9f6a-4f02-91a2-6267d783fa78	2023-12-28	Warnings, Adverse reactions	Exact identifier rxcui: 349472
IRESSA	GEFITINIB	AstraZeneca Pharmaceuticals LP	827d60e8-7e07-41b7-c28b-49ef1c4a5a41	2023-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 349472
Gefitinib	GEFITINIB	Qilu Pharmaceutical Co., Ltd.	0afc12dd-12f8-4def-9027-f38412a862b9	2023-02-22	Warnings, Adverse reactions	Exact identifier rxcui: 349472
Gefitinib	GEFITINIB	Teva Pharmaceuticals, Inc.	3dd135f0-5db1-4236-9756-04533b66dc9d	2022-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 349472

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
827d60e8-7e07-41b7-c28b-49ef1c4a5a41	gefitinib 250 MG Oral Tablet [PSN] · gefitinib 250 MG Oral Tablet [SCD]	2	19	These highlights do not include all the information needed to use IRESSA ® safely and effectively. See full prescribing information for IRESSA. IRESSA (gefitinib) tablets for oral use Initial U.S. Approval: 2015	20230228
0afc12dd-12f8-4def-9027-f38412a862b9	gefitinib 250 MG Oral Tablet [PSN] · gefitinib 250 MG Oral Tablet [SCD]	2	7	These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS GEFITINIB tablets, for oral use Initial U.S. Approval: 2015	20230222
3dd135f0-5db1-4236-9756-04533b66dc9d	gefitinib 250 MG Oral Tablet [PSN] · gefitinib 250 MG Oral Tablet [SCD]	2	5	These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS . GEFITINIB tablets, for oral use Initial U.S. Approval: 2015	20220228
1a3c0ce7-06a1-4e04-9106-14ddb2a866a5	gefitinib 250 MG Oral Tablet [PSN] · gefitinib 250 MG Oral Tablet [SCD]	2	4	These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS. GEFITINIB tablets, for oral use Initial U.S. Approval: 2015	20260310
6402435f-9f6a-4f02-91a2-6267d783fa78	gefitinib 250 MG Oral Tablet [PSN] · gefitinib 250 MG Oral Tablet [SCD]	2	3	These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS. GEFITINIB tablets, for oral use Initial U.S. Approval: 2015	20231228